» Articles » PMID: 17417705

Molecular Modeling of PepT1--towards a Structure

Overview
Journal J Membr Biol
Date 2007 Apr 10
PMID 17417705
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The proton-coupled uptake of di- and tri-peptides is the major route of dietary nitrogen absorption in the intestine and of reabsorption of filtered protein in the kidney. In addition, the transporters involved, PepT1 (SLC15a1) and PepT2 (SLC15a2), are responsible for the uptake and tissue distribution of a wide range of pharmaceutically important compounds, including beta-lactam antibiotics, angiotensin-converting enzyme inhibitors, anti-cancer and anti-viral drugs. PepT1 and PepT2 are large proteins, with over 700 amino acids, and to date there are no reports of their crystal structures, nor of those of related proteins from lower organisms. Therefore there is virtually no information about the protein 3-D structure, although computer-based approaches have been used to both model the transmembrane domain (TM) layout and to produce a substrate binding template. These models will be discussed, and a new one proposed from homology modeling rabbit PepT1 to the recently crystallized bacterial transporters LacY and GlpT. Understanding the mechanism by which PepT1 and PepT2 bind and transport their substrates is of great interest to researchers, both in academia and in the pharmaceutical industries.

Citing Articles

Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs).

Luo Y, Gao J, Jiang X, Zhu L, Zhou Q, Murray M Pharmaceutics. 2023; 15(10).

PMID: 37896276 PMC: 10609898. DOI: 10.3390/pharmaceutics15102517.


Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Viennois E, Pujada A, Zen J, Merlin D Compr Physiol. 2018; 8(2):731-760.

PMID: 29687900 PMC: 7188079. DOI: 10.1002/cphy.c170032.


Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.

Colas C, Masuda M, Sugio K, Miyauchi S, Hu Y, Smith D Mol Pharm. 2017; 14(12):4685-4693.

PMID: 29111754 PMC: 5826771. DOI: 10.1021/acs.molpharmaceut.7b00775.


Di- and tripeptide transport in vertebrates: the contribution of teleost fish models.

Verri T, Barca A, Pisani P, Piccinni B, Storelli C, Romano A J Comp Physiol B. 2016; 187(3):395-462.

PMID: 27803975 DOI: 10.1007/s00360-016-1044-7.


Bile acid-regulated peroxisome proliferator-activated receptor-α (PPARα) activity underlies circadian expression of intestinal peptide absorption transporter PepT1/Slc15a1.

Okamura A, Koyanagi S, Dilxiat A, Kusunose N, Chen J, Matsunaga N J Biol Chem. 2014; 289(36):25296-305.

PMID: 25016014 PMC: 4155691. DOI: 10.1074/jbc.M114.577023.


References
1.
Terada T, Saito H, Mukai M, Inui K . Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1. FEBS Lett. 1996; 394(2):196-200. DOI: 10.1016/0014-5793(96)00952-0. View

2.
Abramson J, Smirnova I, Kasho V, Verner G, Kaback H, Iwata S . Structure and mechanism of the lactose permease of Escherichia coli. Science. 2003; 301(5633):610-5. DOI: 10.1126/science.1088196. View

3.
McGuffin L, Bryson K, Jones D . The PSIPRED protein structure prediction server. Bioinformatics. 2000; 16(4):404-5. DOI: 10.1093/bioinformatics/16.4.404. View

4.
Wilson M, Meredith D, Manning Fox J, Manoharan C, Davies A, Halestrap A . Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem. 2005; 280(29):27213-21. DOI: 10.1074/jbc.M411950200. View

5.
Kaback H . Structure and mechanism of the lactose permease. C R Biol. 2005; 328(6):557-67. DOI: 10.1016/j.crvi.2005.03.008. View